Drug Eluting Stent, Zotarolimus, Cobalt Chromium, Over The Wire, 3.0mm x 30mm

The Medtronic Resolute Onyx/Onyx Frontier TruCor Zotarolimus-Eluting Stent System is a drug-eluting stent (DES) designed for complex percutaneous coronary interventions (PCI). It features a unique single-wire, sinusoid-formed design using a platinum-iridium core and cobalt alloy shell for superior flexibility, thin struts, and high visibility. It is used for treating narrowings in coronary arteries with diameters of 2.0 mm to 5.0 mm. Key Features and Benefits Single-Wire Technology: The stent is constructed from a single wire, providing a "fluid" range of motion, enhanced conformability, and excellent, uniform strut apposition. Material and Visibility: The structure consists of a platinum-iridium core within a cobalt alloy shell, which provides increased visibility for accurate placement without increasing strut thickness. Thinner Struts: The design utilizes thinner struts compared to previous generations, promoting faster healing and reducing the risk of thrombosis. BioLinx Polymer: The stent is coated with BioLinx polymer and zotarolimus, which is designed for rapid endothelial healing. Complex Intervention Capability: Designed for high bleeding risk (HBR) patients, this stent is indicated for use with as little as 1-month dual antiplatelet therapy (DAPT). Range of Sizes: Covers a broad diameter range (2.0 to 5.0 mm) with overexpansion capabilities up to 6.0 mm. About the Company Legal Status of Firm: Proprietorship Number of Employees: 11 To 25 People Annual Turnover: 25 - 100 Cr company-description: Cardiology is basically a branch of medicine that deals with the disorders of the heart and also with some parts of the circulatory system. This field requires medical diagnosis for further treatment. Therefore, keeping this in mind we are dealing with the interventional range of cardiology products i.e., Angiography and Angioplasty Goods.